Making Pharma’s Post-Covid-19 Future Faster and Smarter

COVID-19 has sparked the reimagining of the pharmaceutical industry, illustrating the possibilities — and benefits — of fully remote commerce.

Read the Full STAT Byline

The COVID-19 pandemic sparked the reimagining of the pharmaceutical industry, illustrating the possibilities — and benefits — of fully remote commerce. Among other things, we’ve learned that bringing drugs to market needn’t be a 10-year slog and that pharma can be smarter, faster, and more efficient.

Saul Helman, MD, and David Weiss outline three lessons for the pharmaceutical industry to carry forward post-COVID:

  1. Infuse agility and responsiveness into the sales force.
  2. Take advantage of opportunities to expedite the path to market.
  3. Simplify the supply chain with proactive strategies to address its complexities. 

Read their full byline in STAT.

About the Experts

Back to top